Trials / Conditions / Esthesioneuroblastoma
Esthesioneuroblastoma
7 registered clinical trials studyying Esthesioneuroblastoma — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496 | University of Arizona | Phase 1 / Phase 2 |
| Recruiting | Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for NCT06607692 | Fundación de investigación HM | Phase 1 / Phase 2 |
| Completed | Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON). NCT05012098 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | A Natural History Study of Children and Adults With Olfactory Neuroblastoma NCT04755205 | National Cancer Institute (NCI) | — |
| Recruiting | 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. NCT04081701 | Weill Medical College of Cornell University | Phase 4 |
| Recruiting | Long-Term Longitudinal QoL in Patients Undergoing EEA NCT04087902 | Ohio State University | — |
| Unknown | Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy NCT01586767 | Massachusetts General Hospital | N/A |